"The human mind treats a new idea the same way the body treats a strange protein; it rejects it."
Medawar's initial studies were devoted to cell culture and peripheral nerve regeneration. He pioneered the use of mathematical modeling in tissue culture, applying it to the analysis of cell growth, morphology and development. During World War II, he served at the Burns Unit of Glasgow's Royal Infirmary. The intense bombings in Britain caused many victims with extensive burns and the rejection of skin grafts was one of the largest medical care problems.
Medical knowledge at the time stated that the prevention of skin rejection was a matter of surgical skill. Studying grafted patients, Medawar demonstrated that skin graft rejection was fundamentally a biological problem. Studying the time to rejection and evaluating graft invasion by lymphocytes, he developed the theory of immunity for transplants. He was a pioneer in the mechanisms of acquired immune tolerance and immunomodulation with corticosteroids, which produced the first positive impact on the increased survival of renal transplants.
In 1960, in recognition for his outstanding scientific contribution, Peter Medawar received the Nobel Prize in Physiology and Medicine, along with the Australian Frank Burnet, for establishing the basis of immune tolerance and for creating the antilymphocyte serum, which definitely changed the history of post-transplant organ rejection. In 1962, he was appointed head of the largest medical research laboratory in the UK, the National Institute for Medical Research, and in 1965 received the title of Sir, granted by Queen Elizabeth II. He was also the founder and first president of the International Transplantation Society. (1984) . In 1986, he published his autobiography, a year before his death, the title of which highlights the contrast between his life with the physical limitations caused by the disease and his preserved lucidity: Memoir of a Thinking Radish. In 1961, the award-winning scientist returned to Rio de Janeiro, where he received the title of Doctor Honoris Causa from the University of Brazil (UB) -today UFRJ. 3 At the time, he stated that his return to Brazil, after so many years, was one of the greatest emotions of his life. Peter met with Brazilian scientists delivering two lectures, at the Brazilian Academy of Sciences and at the UB Biophysics Institute.
The State Medical Academy of Rio de Janeiro (ACAMERJ) created the Peter Brian Medawar Medal, as a way to honor the distinguished scientist and perpetuate his name in the Brazilian academia. In 1990, the Transplantation Society created the Medawar Prize, a tribute to its co-founder, considered one of the world's most prestigious scientific prizes, already awarded to the highest academic contributions in immunology and transplantation.
On the centenary of his birth, all tributes to the memory of Peter Brian Medawar will be fair and well deserved. The Brazilian Society of Nephrology could not refrain from expressing its appreciation and pay tribute to Peter Medawar, a native Brazilian, who with his exceptional intellectual capacity decisively contributed to change the history of medicine.
